Related Experiment Video
Updated: Feb 24, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Nonmotor Features in Atypical Parkinsonism
Kailash P Bhatia1, Maria Stamelou2
1Institute of Neurology, London, United Kingdom.
Atypical parkinsonism (AP) involves multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). Nonmotor symptoms significantly impact AP patient quality of life and prognosis, posing clinical challenges.
Area of Science:
- Neurology
- Neurodegenerative Diseases
- Clinical Medicine
Background:
- Atypical parkinsonism (AP) encompasses distinct disorders like multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD).
- While motor symptoms are well-documented, nonmotor features in AP have been historically under-researched.
- AP presents a broad spectrum of clinical manifestations, including classic syndromes such as MSA-parkinsonism (MSA-P), MSA-cerebellar type (MSA-C), Richardson's syndrome, and corticobasal syndrome.
Purpose of the Study:
- To highlight the significance of nonmotor features in atypical parkinsonism.
- To underscore the impact of nonmotor symptoms on patient quality of life and prognosis.
- To emphasize the diagnostic and therapeutic challenges posed by nonmotor symptoms in AP.
Main Methods:
- Review of existing literature on nonmotor symptoms in AP.
- Analysis of clinical presentations of MSA, PSP, and CBD.
- Identification of common and prominent nonmotor features across AP subtypes.
Main Results:
- Autonomic dysfunction is a key nonmotor feature in MSA, alongside gastrointestinal issues, sleep disturbances, and pain.
- Cognitive and neuropsychiatric symptoms are predominant nonmotor features in PSP and CBD.
- Nonmotor symptoms are crucial for differential diagnosis from Parkinson's disease.
Conclusions:
- Nonmotor features significantly affect the quality of life and prognosis of patients with atypical parkinsonism.
- Understanding and managing nonmotor symptoms is essential for comprehensive AP care.
- Further research is needed to address the diagnostic and therapeutic challenges of nonmotor symptoms in AP.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Antipsychotic Drugs: Typical and Atypical Agents

